(Q72728538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Natulan (Procarbazine) combined with radiotherapy in management of inoperable malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1 reference

10.1136/BMJ.2.5476.1473

https://api.crossref.org/works/10.1136/BMJ.2.5476.1473

11 July 2023

author name string

G. Falkson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5892196

11 July 2023

P. C. de Villiers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5892196

11 July 2023

H. C. Falkson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5892196

11 July 2023

T. Fichardt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5892196

11 July 2023

language of work or name

English

0 references

publication date

1 December 1965

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://europepmc.org/articles/PMC1847069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5892196

https://europepmc.org/articles/PMC1847069?pdf=render

11 July 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5892196

https://syndication.highwire.org/content/doi/10.1136/bmj.2.5476.1473

11 July 2023

1 reference

Crossref

DOI

10.1136/BMJ.2.5476.1473

https://api.crossref.org/works/10.1136/BMJ.2.5476.1473

11 July 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

5476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1473-1474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide

28 October 2019

cites work

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/5892196

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

NATULAN IN MANAGEMENT OF LATE HODGKIN'S DISEASE, OTHER LYMPHORETICULAR NEOPLASMS, AND MALIGNANT MELANOMA.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/5892196

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.2.5476.1473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5892196%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference